Consolidation is going to continue. It's not a new round or an old round. It's a continuation of what's been going on since late 80's. Any company with a market cap of $40 billion or lower can be bought for cash by the big players. |
It's too early to tell. What you need is a drug that reduces weight with no side-effect problems. Drugs like that are very rare and often don't exist. |
They were pretty solid earnings. But it's clear that the market thinks Merck isn't quite ready to deliver on its projections. |